AI assistant
NEOGENOMICS INC — Director's Dealing 2022
Mar 4, 2022
32227_dirs_2022-03-03_c2756b55-a87e-4ddd-b13e-ed06b6efbdb2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-03-01
Reporting Person: CARDOZA GEORGE (President & COO, Lab Ops)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-01 | Common Stock | F | 503 | — | Disposed | 244996 | Direct |
| 2022-03-02 | Common Stock | F | 839 | — | Disposed | 244157 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (50000.0) | 50000 | Direct |
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (192500.0) | 192500 | Direct |
| Stock Option (Right to Buy) | $19.6 | 2024-03-01 | Common Stock (51459.0) | 51459 | Direct |
| Stock Option (Right to Buy) | $28.33 | 2027-03-02 | Common Stock (48768.0) | 48768 | Direct |
| Stock Option (Right to Buy) | $53.17 | 2028-03-02 | Common Stock (35171.0) | 35171 | Direct |
| Stock Option (Right to Buy) | $43.95 | 2028-07-05 | Common Stock (40502.0) | 40502 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock.
F2: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.
F3: On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F4: On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F5: On March 1, 2019, Mr. Cardoza was granted 51,459 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F6: On March 2, 2020, Mr. Cardoza was granted 48,768 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F7: On March 2, 2021, Mr. Cardoza was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F8: On July 5, 2021, Mr. Cardoza was granted 40,502 stock options. These options vest ratably over the first four anniversary dates of the grant date.